Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 50090-6062

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 50090-6062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lisinopril)

Chemical structure diagram of the active ingredient Lisinopril and Hydrochlorothiazide, as presented in the product label. The image depicts the molecular arrangement including atoms and bonds, with a depiction of the hydrate form (2H2O).*

FDA Label Image

Chemical Structure (HCTZ)

Chemical structure diagram of the active ingredient Lisinopril and Hydrochlorothiazide, showing molecular bonds and layout of atoms as presented in the FDA SPL submission.*

FDA Label Image

Label Image (Lbl500906062)

Lisinopril and Hydrochlorothiazide Tablets 10 mg/12.5 mg oral tablets packaging label from A-S Medication Solutions. The label includes dosage information, stability storage instructions, and package quantity of 30 tablets. It also shows the lot number and manufacturing details for this prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.